Express Pharma - Page 4 of 2010 - Express Pharma

Indian pharma companies focus on innovative research in foreign countries through dedicated entities

Namit Joshi takes charge as Chairman of Pharmexcil

Eco-conscious packaging: A strategic opportunity

B&R drives adaptive manufacturing solutions in pharma production

SPARC partners with UCSF and Tiller Therapeutics to license oncology asset

Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025

Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets

Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData

Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData

Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU

Biocon Biologics’ Ustekinumab Biosimilar receives positive CHMP opinion

Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector

Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio